Scholarlink

<p><i>Streptococcus pneumoniae</i> (the pneumococcus) is a human bacterial pathogen and the major cause of bacterial pneumonia, which can further develop into sepsis. The pneumococcus has evolved over 107 antigenically-distinct serotypes that are defined by the chemical composition of its capsule; its major virulence factor and the main protective antigen within the vaccine. Owing to its capsule diversification, certain serotypes are known for being more effective at either colonization or invasiveness. It has historically been accepted that these differences are due to the chemical properties of the capsule itself, whose biosynthetic genes are encoded in a single capsular polysaccharide (cps) operon. Here we show that infection outcomes can also be the result of a serotype’s subtle, natural variations within the regulatory region which results in unique transcriptional control of the <i>cps</i> locus. We propose that these data explain, in part, how this pathogen might rapidly evolve its capsule expression to accommodate evolutionary pressures introduced from pneumococcal vaccines, without having to rely on genetic recombination.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Transcriptional regulation of the pneumococcal capsule can dictate serotype-specific infection

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月9日

查看全文
  • Michela Marra,
  • Ozcan Gazioglu,
  • David G. Glanville,
  • Victoria M. Harper-Cummings,
  • Silvia Santana-Krimskaya,
  • Abby R. Kroken,
  • Adonis D’Mello,
  • Feroze A. Ganaie,
  • Moon H. Nahm,
  • Hervé Tettelin,
  • Carlos J. Orihuela,
  • Hasan Yesilkaya,
  • Andrew T. Ulijasz

摘要

Streptococcus pneumoniae (the pneumococcus) is a human bacterial pathogen and the major cause of bacterial pneumonia, which can further develop into sepsis. The pneumococcus has evolved over 107 antigenically-distinct serotypes that are defined by the chemical composition of its capsule; its major virulence factor and the main protective antigen within the vaccine. Owing to its capsule diversification, certain serotypes are known for being more effective at either colonization or invasiveness. It has historically been accepted that these differences are due to the chemical properties of the capsule itself, whose biosynthetic genes are encoded in a single capsular polysaccharide (cps) operon. Here we show that infection outcomes can also be the result of a serotype’s subtle, natural variations within the regulatory region which results in unique transcriptional control of the cps locus. We propose that these data explain, in part, how this pathogen might rapidly evolve its capsule expression to accommodate evolutionary pressures introduced from pneumococcal vaccines, without having to rely on genetic recombination.